Rasmus Christensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rasmus Christensen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Julius Lauritzen
Department of Cardiothoracic & Vascular Surgery Aarhus University Hospital Aarhus Denmark
2 shared publications Søren Rytter
Department of Clinical Medicine Aarhus University Aarhus Denmark
2 shared publicationsAnnemarie Brüel
Department of Biomedicine Aarhus University Aarhus C Denmark
1 shared publication- Annemarie Brüel
Aarhus University
1 shared publication Emil Toft Petersen
AutoRSA Research Group, Orthopaeadic Research Unit Aarhus University Hospital Aarhus N Denmark
1 shared publication- Emil Toft Petersen
AutoRSA Research Group, Orthopaedic Research Unit, Aarhus University Hospital, Aarhus, Denmark
1 shared publication
Latest Publications
- Open Access
- 27 May 2022
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 41 (2) , 436-446
Evaluation of automated radiostereometric image registration in total knee arthroplasty utilizing a synthetic‐based and a CT‐based volumetric model
Radiostereometic analysis (RSA) is an accurate method for rigid body pose (position and orientation) in three‐dimensional space. Traditionally, RSA is based on insertion of periprosthetic tantalum markers and manual implant contour selection which limit clinically application. We propose an automated image registration technique utilizing digitally reconstructed radiographs (DRR) of computed tomography (CT) volumetric bone models (autorsa‐bone) as a substitute for tantalum markers. Furthermore, an automated synthetic volumetric representation of total knee arthroplasty implant models (autorsa‐volume) to improve previous silhouette‐projection methods (autorsa‐surface). As reference, we investigated the accuracy of implanted tantalum markers (marker) or a conventional manually contour‐based method (mbrsa) for the femur and tibia. The data are presented as mean (standard deviation). The autorsa‐bone method displayed similar accuracy of −0.013 (0.075) mm compared to the gold standard method (marker) of −0.013 (0.085). The autorsa‐volume with 0.034 (0.106) mm did not markedly improve the autorsa‐surface with 0.002 (0.129) mm, and none of these reached the mbrsa method of −0.009 (0.094) mm. In conclusion, marker‐free RSA is feasible with similar accuracy as gold standard utilizing DRR and CT obtained volumetric bone models. Furthermore, utilizing synthetic generated volumetric implant models could not improve the silhouette‐based method. However, with a slight loss of accuracy the autorsa methods provide a feasible automated alternative to the semi‐automated method.
- 27 May 2022
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 41 (2) , 436-446
Open AccessEvaluation of automated radiostereometric image registration in total knee arthroplasty utilizing a synthetic‐based and a CT‐based volumetric model
Radiostereometic analysis (RSA) is an accurate method for rigid body pose (position and orientation) in three‐dimensional space. Traditionally, RSA is based on insertion of periprosthetic tantalum markers and manual implant contour selection which limit clinically application. We propose an automated image registration technique utilizing digitally reconstructed radiographs (DRR) of computed tomography (CT) volumetric bone models (autorsa‐bone) as a substitute for tantalum markers. Furthermore, an automated synthetic volumetric representation of total knee arthroplasty implant models (autorsa‐volume) to improve previous silhouette‐projection methods (autorsa‐surface). As reference, we investigated the accuracy of implanted tantalum markers (marker) or a conventional manually contour‐based method (mbrsa) for the femur and tibia. The data are presented as mean (standard deviation). The autorsa‐bone method displayed similar accuracy of −0.013 (0.075) mm compared to the gold standard method (marker) of −0.013 (0.085). The autorsa‐volume with 0.034 (0.106) mm did not markedly improve the autorsa‐surface with 0.002 (0.129) mm, and none of these reached the mbrsa method of −0.009 (0.094) mm. In conclusion, marker‐free RSA is feasible with similar accuracy as gold standard utilizing DRR and CT obtained volumetric bone models. Furthermore, utilizing synthetic generated volumetric implant models could not improve the silhouette‐based method. However, with a slight loss of accuracy the autorsa methods provide a feasible automated alternative to the semi‐automated method.
- 1 December 2021
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 30 (12) , 1942-1948
Preoperative CHA2DS2-VASc Score is Associated With Postoperative Survival Following Surgical Ablation Concomitantly With Other Cardiac Surgery
- 1 December 2021
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 30 (12) , 1942-1948
Preoperative CHA2DS2-VASc Score is Associated With Postoperative Survival Following Surgical Ablation Concomitantly With Other Cardiac Surgery
- 8 October 2020
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 39 (3) , 597-608
Assessment of knee kinematics with dynamic radiostereometry: Validation of an automated model‐based method of analysis using bone models
Radiostereometic analysis (RSA) is a precise method for the functional assessment of joint kinematics. Traditionally, the method is based on tracking of surgically implanted bone markers and analysis is user intensive. We propose an automated method of analysis based on models generated from computed tomography (CT) scans and digitally reconstructed radiographs. The study investigates method agreement between marker‐based RSA and the CT bone model‐based RSA method for assessment of knee joint kinematics in an experimental setup. Eight cadaveric specimens were prepared with bone markers and bone volume models were generated from CT‐scans. Using a mobile fixture setup, dynamic RSA recordings were obtained during a knee flexion exercise in two unique radiographic setups, uniplanar and biplanar. The method agreement between marker‐based and CT bone model‐based RSA methods was compared using bias and LoA. Results obtained from uniplanar and biplanar recordings were compared and the influence of radiographic setup was considered for clinical relevance. The automated method had a bias of −0.19 mm and 0.11° and LoA within ±0.42 mm and ±0.33° for knee joint translations and rotations, respectively. The model pose estimation of the tibial bone was more precise than the femoral bone. The radiographic setup had no clinically relevant effect on results. In conclusion, the automated CT bone model‐based RSA method had a clinical precision comparable to that of marker‐based RSA. The automated method is non‐invasive, fast, and clinically applicable for functional assessment of knee kinematics and pathomechanics in patients.
- 8 October 2020
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 39 (3) , 597-608
Assessment of knee kinematics with dynamic radiostereometry: Validation of an automated model‐based method of analysis using bone models
Radiostereometic analysis (RSA) is a precise method for the functional assessment of joint kinematics. Traditionally, the method is based on tracking of surgically implanted bone markers and analysis is user intensive. We propose an automated method of analysis based on models generated from computed tomography (CT) scans and digitally reconstructed radiographs. The study investigates method agreement between marker‐based RSA and the CT bone model‐based RSA method for assessment of knee joint kinematics in an experimental setup. Eight cadaveric specimens were prepared with bone markers and bone volume models were generated from CT‐scans. Using a mobile fixture setup, dynamic RSA recordings were obtained during a knee flexion exercise in two unique radiographic setups, uniplanar and biplanar. The method agreement between marker‐based and CT bone model‐based RSA methods was compared using bias and LoA. Results obtained from uniplanar and biplanar recordings were compared and the influence of radiographic setup was considered for clinical relevance. The automated method had a bias of −0.19 mm and 0.11° and LoA within ±0.42 mm and ±0.33° for knee joint translations and rotations, respectively. The model pose estimation of the tibial bone was more precise than the femoral bone. The radiographic setup had no clinically relevant effect on results. In conclusion, the automated CT bone model‐based RSA method had a clinical precision comparable to that of marker‐based RSA. The automated method is non‐invasive, fast, and clinically applicable for functional assessment of knee kinematics and pathomechanics in patients.
- 27 July 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (9) , 2216-2223
Discontinuation of anticoagulants after successful surgical ablation of atrial fibrillation
Background The decision of whether to continue oral anticoagulation therapy (OAT) after successful surgical ablation of atrial fibrillation is challenging, and current guidelines provide no specific recommendations on whether or not it is safe to terminate OAT. Therefore, the aim of this study was to assess long‐term outcomes in patients who either did or did not, receive OAT after surgical ablation of atrial fibrillation. Methods In a prospective follow‐up study, patients were included if surgical ablation of atrial fibrillation concomitantly with other cardiac surgery was done, between 2004 and 2018 at Aarhus University Hospital, Denmark. After 12 months, OAT was discontinued if: (a) sinus rhythm was documented by electrocardiogram, (b) atrial fibrillation was absent on 5‐day Holter monitoring, (c) CHADS2 score ≤2, and (d) no other indications for OAT were present. Follow‐up was ended in April 2019. Results A total of 560 patients underwent surgical ablation of which 436 patients reached the baseline at 12 months; 286 patients received OAT, and 150 had OAT discontinued. Survival analysis revealed no differences between the two groups (P = .723). Mean survival time in the group receiving OAT was 5.3 ± 3.3 years, compared to 5.1 ± 3.0 years in the group where OAT was discontinued (P = .784). There was no difference in major adverse cardiac and cerebrovascular events between the two groups (P = .846). Conclusion Discontinuation of OAT is safe in patients with a CHADS2 score ≤2 following successful surgical ablation and left atrial appendage occlusion. This conclusion needs to be confirmed in randomized trials.
- 27 July 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (9) , 2216-2223
Discontinuation of anticoagulants after successful surgical ablation of atrial fibrillation
Background The decision of whether to continue oral anticoagulation therapy (OAT) after successful surgical ablation of atrial fibrillation is challenging, and current guidelines provide no specific recommendations on whether or not it is safe to terminate OAT. Therefore, the aim of this study was to assess long‐term outcomes in patients who either did or did not, receive OAT after surgical ablation of atrial fibrillation. Methods In a prospective follow‐up study, patients were included if surgical ablation of atrial fibrillation concomitantly with other cardiac surgery was done, between 2004 and 2018 at Aarhus University Hospital, Denmark. After 12 months, OAT was discontinued if: (a) sinus rhythm was documented by electrocardiogram, (b) atrial fibrillation was absent on 5‐day Holter monitoring, (c) CHADS2 score ≤2, and (d) no other indications for OAT were present. Follow‐up was ended in April 2019. Results A total of 560 patients underwent surgical ablation of which 436 patients reached the baseline at 12 months; 286 patients received OAT, and 150 had OAT discontinued. Survival analysis revealed no differences between the two groups (P = .723). Mean survival time in the group receiving OAT was 5.3 ± 3.3 years, compared to 5.1 ± 3.0 years in the group where OAT was discontinued (P = .784). There was no difference in major adverse cardiac and cerebrovascular events between the two groups (P = .846). Conclusion Discontinuation of OAT is safe in patients with a CHADS2 score ≤2 following successful surgical ablation and left atrial appendage occlusion. This conclusion needs to be confirmed in randomized trials.